Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Disorder

NCT07487155 | Not Yet Recruiting

• 2 other identifiers: 29BRC25.0324 - JUSTICE-TDAHIDRCB
• Study Type: interventional
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

Substance use disorders (SUD) and attention deficit disorder with or without hyperactivity (ADHD) are frequently co-morbid, particularly among people under court supervision. The coexistence of these disorders increases the social and legal vulnerability of individuals. Better identification of ADHD in vulnerable people with SUD is essential to improving their care. This project aims to provide appropriate support for this at-risk population.

Conditions

Attention Deficit Disorder With Hyperactivity (ADHD); Substance Use Disorder (SUD)

Outcome Measures

Primary Outcomes (1)

• 80% of patients participated in the workshops

  The primary outcome measure is the acceptability of the program to participants in the pilot workshops, gathered through: * Semi-structured pre- and post-intervention interviews * A Likert scale * Workshop participation rate (at least 80%)

  From enrollment to the end of wordshop at 6 months

Secondary Outcomes (1)

• SF-12 quality of life

  From enrollment to the end of wordshop at 6 months

Study Arms (1)

Workshops

EXPERIMENTAL

Workshops with a small group of patients.

Other: Workshop

Interventions

Workshop OTHER

Assess the 5 workshops, co-constructed by the scientific committee and thanks to feedback from the qualitative study

Workshops

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adult, under the supervision of the justice system or monitored by a correctional facility
• Diagnosis of Substance Use Disorder (SUD)
• Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD)
• No objection from the patient
• Affiliated with a Social Security system

You may not qualify if:

• Severe or decompensated psychiatric disorders
• Severe cognitive impairment
• Lack of understanding of the French language
• Refusal to participate

Sponsors & Collaborators

• University Hospital, Brest: lead

Study Sites (1)

CHU Brest

Brest, 29200, France

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity; Substance-Related Disorders

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior Disorders; Neurodevelopmental Disorders; Mental Disorders; Chemically-Induced Disorders

Central Study Contacts

Marie BARAIS, MD

CONTACT

+332 98 01 64 02; marie.barais@gmail.com

Tiphaine MENEZ

CONTACT

+33230338460; tiphaine.menez@chu-brest.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 12, 2026
• First Posted: March 23, 2026
• Study Start (Estimated): June 1, 2026
• Primary Completion (Estimated): December 1, 2027
• Study Completion (Estimated): December 1, 2027
• Last Updated: March 23, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: Data will be available after the publication of result and ending fifteen years following the last visit of the last patient.
• Access Criteria: Data access requests will be reviewed by the internal committee of BrestUH. Requestors will be required to sign and complete a data access agreement.

Locations

FR (1)